Low-affinity state beta1-adrenoceptor-induced vasodilation in SHR

被引:7
作者
Mallem, MY [1 ]
Reculeau, O [1 ]
Le Coz, O [1 ]
Gogny, M [1 ]
Desfontis, JC [1 ]
机构
[1] Ecole Natl Vet, UPSP 5304, Nantes, France
关键词
low-affinity state; beta-adrenoceptor; SHR; potassium channel; vasodilation; enalapril; losartan;
D O I
10.1016/j.peptides.2005.03.018
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Low-affinity state beta 1-adrenoceptor (beta(1)-AR) was functionally expressed in some blood vessels and was different from beta(1), beta(2) and beta(3)-AR. In rat aorta, low-affinity state beta(1)-AR activation produced an endothelium-independent relaxation which was impaired in spontaneously hypertensive rats (SHRs). In the present work, we investigated whether renin-angiotensin system was involved in this alteration by evaluating the effects of enalapril, an angiotensin converting enzyme (ACE) inhibitor or losartan, an AT1 angiotensin receptor antagonist. Cumulative concentration-response curves to low-affinity state beta(1)-AR agonists (CGP 12177, cyanopindolol or alprenolol) and to NS 1619, a large conductance Ca2+-activated K+ channels (BK) agonist were performed in denuded aortic rings isolated from control or treated Wistar Kyoto (WKY) rats or SHRs in different experimental conditions. The low-affinity state beta(1)-AR-mediated aortic vasodilation was impaired in 5 and 12 weeks old SHRs when compared to age-matched WKY Twelve days enalapril (5 mg/kg/day) or losartan (15 mg/kg/day) treatments reduced systolic blood pressure (SBP) only in 12 weeks old SHRs whereas no significant change was observed in other groups. These treatments improved low-affinity state beta(1)-AR effect only in SHRs groups. In 12 weeks old WKY rats, CGP 12177-induced relaxation was insensitive to glibenclamide, a K-ATP(+) channel blocker, but was reduced by TEA or iberiotoxin, two large conductance Ca2+-activated K+ channel (BK) blockers. The impairment of NS 1619-induced vasodilation in both 5 and 12 weeks old SHRs was restored by enalapril or losartan. These results suggested that improvement of the low-affinity state beta(1)-AR-mediated vasodilation in 5 and 12 weeks old SHRs could be attributed to enhanced BK channels-induced hyperpolarization in SHRs independently of lowering of SBP. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1463 / 1467
页数:5
相关论文
共 18 条
[1]   Modulation of the molecular composition of large conductance, Ca2+activated K+ channels in vascular smooth muscle during hypertension [J].
Amberg, GC ;
Bonev, AD ;
Rossow, CF ;
Nelson, MT ;
Santana, LF .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (05) :717-724
[2]   Downregulation of the BK channel β1 subunit in genetic hypertension [J].
Amberg, GC ;
Santana, LF .
CIRCULATION RESEARCH, 2003, 93 (10) :965-971
[3]   QUINAPRIL TREATMENT AND ARTERIAL SMOOTH-MUSCLE RESPONSES IN SPONTANEOUSLY HYPERTENSIVE RATS [J].
ARVOLA, P ;
RUSKOAHO, H ;
WUORELA, H ;
PEKKI, A ;
VAPAATALO, H ;
PORSTI, I .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 108 (04) :980-990
[4]   Ca2+-activated K+ channels underlying the impaired acetylcholine-induced vasodilation in 2K-1C hypertensive rats [J].
Callera, GE ;
Yogi, A ;
Tostes, RC ;
Rossoni, LV ;
Bendhack, LM .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 309 (03) :1036-1042
[5]   Impaired vasodilator function in hypertension - The role of alterations in receptor-G protein coupling [J].
Feldman, RD ;
Gros, R .
TRENDS IN CARDIOVASCULAR MEDICINE, 1998, 8 (07) :297-305
[6]   Diminished β-adrenoceptor-mediated relaxation of femoral arteries from young spontaneously hypertensive rats [J].
Fujimoto, S ;
Fujimoto, KS ;
Moriyama, A .
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, 2001, 87 (2-3) :178-186
[7]   The putative β4-adrenergic receptor is a novel state of the β1-adrenergic receptor [J].
Granneman, JG .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2001, 280 (02) :E199-E202
[8]   Losartan and enalapril therapies enhance vasodilatation in the mesenteric artery of spontaneously hypertensive rats [J].
Kähönen, M ;
Tolvanen, JP ;
Kalliovalkama, J ;
Wu, XM ;
Karjala, K ;
Mäkynen, H ;
Pörsti, I .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 368 (2-3) :213-222
[9]  
KENAKIN T, 1997, PHARM ANAL DRUG RECE, P366
[10]  
KNAUS HG, 1994, J BIOL CHEM, V269, P3921